Élise Duchesne
NMD4C Working Group Member
Associate Professor, Department of Health Sciences, Université du Québec à Chicoutimi
Researcher, Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN)
NMD4C Working Group(s): Biobanking
Email ÉliseRead more about Élise
Research Interests: muscle plasticity, skeletal muscle physiology, macrophage, muscle biology / physiology, cell culture, innate immunity, flow cytometry, cellular immunology, muscle damage
Academic web profileGoogle Scholar profile
ORCiD profile
Biography
Dr. Duchesne graduated from Laval University’s physiotherapy program in 2006. Her passion for research led her to undertake a master’s degree followed by a Ph.D. from 2006 to 2012. Her thesis focused on skeletal muscle injuries, more specifically on the contribution of inflammation to the repair process. In January 2012, Dr. Duchesne was hired as a professor/researcher in the Université du Québec à Chicoutimi’s physiotherapy program.
As an independent researcher, her works focus namely on developing rehabilitation interventions. She carried out original and innovative experimental designs based on her knowledge in muscle physiology and her access to the large cohorts of NMD patients found in the Saguenay–Lac-St-Jean region such as myotonic dystrophy type I (DM1).
Her contributions to the field of neuromuscular diseases include the clinical and fundamental study of strength training effects on skeletal muscle impairments, the support of clinical trial readiness by reaching international consensus on outcome measures, the documentation of metrological properties, the documentation natural history of the disease and the establishment of a phenotypic data and biological material biobank.
Recent publications
Roussel, MP, Fiset, MM, Gauthier, L, Lavoie, C, McNicoll, É, Pouliot, L et al.. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study. J Neurol. 2021.268 (11)4221-4237 PMID:33907889
Lessard, I, Gaboury, S, Gagnon, C, Bouchard, K, Chapron, K, Lavoie, M et al.. Effects and Acceptability of an Individualized Home-Based 10-Week Training Program in Adults with Myotonic Dystrophy Type 1. J Neuromuscul Dis. 2021.8 (1)137-149 PMID:33252090
Roussel, MP, Hébert, LJ, Duchesne, E. Strength-training effectively alleviates skeletal muscle impairments in myotonic dystrophy type 1. Neuromuscul Disord. 2020.30 (4)283-293 PMID:32340814
Duchesne, E, Hébert, LJ, Mathieu, J, Côté, I, Roussel, MP, Gagnon, C et al.. Validity of the Mini-BESTest in adults with myotonic dystrophy type 1. Muscle Nerve. 2020.62 (1)95-102 PMID:32314404
Roussel, MP, Morin, M, Girardin, M, Fortin, AM, Leone, M, Mathieu, J et al.. Training program-induced skeletal muscle adaptations in two men with myotonic dystrophy type 1. BMC Res Notes. 2019.12 (1)526 PMID:31429798
Roussel, MP, Hébert, LJ, Duchesne, E. Intra-Rater Reliability and Concurrent Validity of Quantified Muscle Testing for Maximal Knee Extensors Strength in Men with Myotonic Dystrophy Type 1. J Neuromuscul Dis. 2019.6 (2)233-240 PMID:31127731
Roussel, MP, Morin, M, Gagnon, C, Duchesne, E. Correction to: What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review. BMC Musculoskelet Disord. 2019.20 (1)244 PMID:31122216
Roussel, MP, Morin, M, Gagnon, C, Duchesne, E. What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review. BMC Musculoskelet Disord. 2019.20 (1)101 PMID:30836978
Gagnon, C, Petitclerc, É, Kierkegaard, M, Mathieu, J, Duchesne, É, Hébert, LJ et al.. A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1. J Neurol. 2018.265 (7)1698-1705 PMID:29785524
Chapron, K, Plantevin, V, Thullier, F, Bouchard, K, Duchesne, E, Gaboury, S et al.. A More Efficient Transportable and Scalable System for Real-Time Activities and Exercises Recognition. Sensors (Basel). 2018.18 (1) PMID:29346286
See more on PubMed